hydrocodone bitartrate and acetaminophen tablet
INDICATIONS AND USAGE Hydrocodone Bitartrate and Acetaminophen Tablets, USP are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration [see WARNINGS ] , reserve hydrocodone bitartrate and acetaminophen tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or opioid combination products): Have not been tolerated or are not expected to be tolerated, Have not provided adequate analgesia or are not expected to provide adequate analgesia Hydrocodone bitartrate and acetaminophen tablets should not be used for an extended period of time unless the pain remains severe enough to require an opioid analgesic and for which alternative treatment options continue to be inadequate.
rhodes pharmaceuticals l.p.
OVAL WHITE R P H5 325
R P H5 325 OVAL WHITE
Related Pills
hydrocodone bitartrate and acetaminophen tablet
rhodes pharmaceuticals l.p.
hydrocodone bitartrate and acetaminophen tablet
rhodes pharmaceuticals l.p.
hydrocodone bitartrate and acetaminophen tablet
rhodes pharmaceuticals l.p.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
HYDROCODONE BITARTRATE AND ACETAMINOPHEN Tablets, USP are supplied as follows: 5 mg/325 mg white to off-white, capsule shape with H5/325 on one side and R bisect P on the other side. Bottles of 100 NDC 42858-201-01 Bottles of 500 NDC 42858-201-50 Unit Dose Packages of 100 (10 tablets × 10 Cards) NDC 42858-201-10 7.5 mg/325 mg white to off-white, capsule shape with H7.5 over 325 on one side and R bisect P on the other side. Bottles of 100 NDC 42858-202-01 Unit Dose Packages of 100 (10 tablets × 10 Cards) NDC 42858-202-10 10 mg/325 mg white to off-white, capsule shape with H10/325 on one side and R bisect P on the other side. Bottles of 100 NDC 42858-203-01 Bottles of 500 NDC 42858-203-50 Bottles of 1000 NDC 42858-203-90 Unit Dose Packages of 100 (10 tablets × 10 Cards) NDC 42858-203-10 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Store
HYDROCODONE BITARTRATE AND ACETAMINOPHEN Tablets securely and dispose of properly [see PRECAUTIONS, Information for Patients/Caregivers ] .
More pills like OVAL R P H5 325